Document Detail

IGF-I Bioactivity Might Reflect Different Aspects of Quality of Life Than Total IGF-I in GH-Deficient Patients During GH Treatment.
MedLine Citation:
PMID:  23295465     Owner:  NLM     Status:  Publisher    
Context:No relationship has been found between improvement in quality of life (QOL) and total IGF-I during GH therapy.Aim:Our aim was to investigate the relationship between IGF-I bioactivity and QOL in GH-deficient (GHD) patients receiving GH for 12 months.Methods:Of 106 GHD patients, 84 on GH treatment discontinued therapy 4 weeks before establishing baseline values and 22 were GH-naive. IGF-I bioactivity was determined by IGF-I kinase receptor activation assay, total IGF-I by immunoassay (Immulite), and QOL by the disease-specific Question on Life Satisfaction Hypopituitarism (QLS-H) module and by the general SF-36 questionnaire (SF-36Q).Results:IGF-I bioactivity increased after 6 months (-2.5 vs -1.9 SD, P <; .001) and did not further increase after 12 months (-1.8 SD, P = .23); total IGF-I increased from -2.3 to -0.9 SD (P <; .001) and to -0.6 SD (P = .005), respectively. QLS-H did not change over 12 months (-0.66 ± 0.16 to -0.56 ± 0.17 SD [P = .42] to -0.68 ± 0.17 SD [P = .22]). The mental component summary of the SF-36Q increased from 47.4 (38.7-52.8) to 50.2 (43.1-55.3) (P = .001) and did not further improve (49.4 [42.1-54.1], P = .19); the physical component summary did not change (47.5 [42.0-54.2] vs 47.0 [41.9-55.3], P = .91, vs 48.3 [39.9-55.4], P = .66). After 12 months, IGF-I bioactivity was related to QLS-H (r = 0.28, P = .01); total IGF-I was not (r = 0.10, P = .37). IGF-I bioactivity and total IGF-I were related to PCS (r = 0.35, P = .001; and r = 0.31, P = .003).Conclusion:IGF-I bioactivity remained subnormal after GH treatment and was positively related to QLS-H, whereas total IGF-I was not. This suggests that IGF-I bioactivity reflects different aspects of QOL than total IGF-I in GHD patients during GH treatment.
Aimee J Varewijck; Steven W J Lamberts; Sebastian J C M M Neggers; Leo J Hofland; Joseph A M J L Janssen
Related Documents :
4014545 - Acute pancreatitis in algeria. report of 221 cases.
23371335 - The effect of a clinical pathway for enhanced recovery of rectal resections on perioper...
11100375 - A retrospective analysis of 88 patients with pancreaticogastrostomy after pancreaticodu...
24881635 - Cost-effectiveness of lumbar discectomy and single-level fusion for spondylolisthesis: ...
17109155 - Intraocular triamcinolone acetonide for macular edema due to crvo. a multifocal-erg and...
11347645 - Acoustic neuromas in the elderly.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-7
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  -     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Role of Pigment Epithelium-Derived Factor in the Pathophysiology and Treatment of Ovarian Hypers...
Next Document:  Circulating IgGs May Modulate IGF-I Receptor Stimulating Activity in a Subset of Patients with Grave...